首页> 外文期刊>Journal of Medical Case Reports >Skin reaction to inhaled tiotropium bromide: a case report
【24h】

Skin reaction to inhaled tiotropium bromide: a case report

机译:吸入噻托溴铵的皮肤反应:一例报告

获取原文
获取外文期刊封面目录资料

摘要

Introduction Systemic reactions to inhaled drugs are rare. To the best of our knowledge, we report the first case of generalized itching related to the use of tiotropium bromide, a long acting inhaled anti-cholinergic agent commonly used to treat chronic obstructive pulmonary disease. Case presentation A 78-year-old Caucasian woman was referred to our facility for allergological evaluation. Our patient had been treated twice with tiotropium for chronic obstructive pulmonary disease and had experienced an allergic reaction with itching. We performed a double-blind placebo-controlled inhalation challenge for our patient with tiotropium and a placebo. Inhalation tests yielded positive results for tiotropium and negative results for the placebo. The results of a skin prick test with tiotropium were negative. Conclusions These findings reveal that tiotropium may elicit immediate skin allergic reactions. The negative result from the skin test suggests that such a reaction is not immunoglobulin E-mediated.
机译:引言对吸入药物的全身反应很少见。据我们所知,我们报道了第一例与使用噻托溴铵有关的全身瘙痒,噻托溴铵是一种长效吸入性抗胆碱能药物,常用于治疗慢性阻塞性肺疾病。病例介绍一名78岁的白人妇女被转介到我们的工厂进行过敏性评估。我们的患者接受了噻托溴铵两次治疗慢性阻塞性肺疾病,并经历了瘙痒的过敏反应。我们对噻托溴铵和安慰剂患者进行了双盲安慰剂对照吸入试验。吸入试验对噻托溴铵产生阳性结果,对安慰剂产生阴性结果。噻托铵的皮肤点刺试验结果为阴性。结论这些发现表明噻托溴铵可能引起立即的皮肤过敏反应。皮肤测试的阴性结果表明这种反应不是免疫球蛋白E介导的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号